Home -> Law Blog Directory -> Intellectual Property Law Blogs -> Two-Seventy-One Patent Blog
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: Two-Seventy-One Patent BlogNYT: Patent Reform "Boon To Lobbyists", Dudas Claims Applications Are Getting "Worse and Worse"
By Peter Zura
In addition to lobbying, the article also focused on the ongoing debate over inequitable conduct. One noteworthy statistic cited in this regard parteins specifically to pharmaceutical patents:
In the last 15 years, the United States Court of Appeals for the Federal Circuit, which handles patent cases, has affirmed findings of inequitable conduct in at least 40 cases, including 14 that involved pharmaceutical or health care products. Similar findings have been issued by federal district judges in an unknown number of cases that were not appealed.One of the more interesting points in the article were the comments of USPTO Director Jon Dudas, who had the following to say:
We are getting more and more unpatentable ideas, worse and worse quality applications. Historically, in the last 40 years, the allowance rate ? the percentage of applications ultimately approved ? hovered around 62 percent to 72 percent. It went up to 72 percent in 2000, but dropped to 43 percent in the first quarter of this year.This comment follows his statement at an IP Symposium earlier this month (reported by EE Times), in which he stated:
We've seen a problem with quality . . . [I question whether the current system is] making it too easy for people who want to file poor [patent] applications?Also, compare this to the comments he made to IAM last month on patent quality:
[W]e?ve determined the quality of patents granted has been improving, and we expect this to continue because of current and future quality initiatives. A major concern we have at the USPTO--and it is a concern I have heard from many IP offices around the world--is the room for improvement in applications coming through our door.Incidentally, IAM had a great article that discussed the "patent quality debate", where various IP leaders commented on patent quality (to see a brief except, click here). Quite interestingly, Alison Brimelow, President of the European Patent Office noted that, in her view, "[i]n spite of anecdotal evidence to the contrary, there is no hard empirical evidence that patent quality has substantially deteriorated in the last five or 10 years."
Full post as published by Two-Seventy-One Patent Blog on April 29, 2008 (boomark / email).
Paxil Lawsuit
Paxil Claims, Lawsuits, and Injuries
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Texas, USA
alleging the Medical Malpractice and Tort Reform Act of 2003 violates several provisions of the Constitution.
Federal Government
Florida residents sue claiming extraordinary delays in judging citizenship applications.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
False Claims
Attorney Robert Arledge ordered to pay $5.8 million after making false Fen Phen settlement claims.

NY Times on patent reform, inequitable conduct
Patent reform 2008 as a house of mirrors
Dudas, IBM's toilet queue patent, and patent quality
USPTO News: Enjoined Rule Will Not Be Applied Retroactively . . . If PTO Prevails in Tafas v. Dudas







